Members

Resource library

Our regulatory position papers and whitepapers on digital health technologies in clinical trials. Three download without an account; a free account opens the rest after email confirmation and personal approval, usually within one business day. No sales calls attached.

4 papers tagged “FDA”
DeviceFit — fit-for-purpose validation Device360 Brochures Free 2 pages

DeviceFit — fit-for-purpose validation

Technical, clinical and operational validation aligned to ISO 14971, IEC 62366-1, FDA QSR, EU MDR Annex I and ICH-GCP.

Download PDF →
Global Reconciliation: FDA, EU, PMDA, NMPA and UK Requirements for DHTs Position papers 11 pages

Global Reconciliation: FDA, EU, PMDA, NMPA and UK Requirements for DHTs

Why the shared requirements carry across markets and the local differences do not — and how to decide when a per-jurisdiction assessment is actually needed.

Read the summary →
Inspection-Ready: What FDA, EU and MHRA Inspectors Look For in DHT Evidence Position papers 9 pages

Inspection-Ready: What FDA, EU and MHRA Inspectors Look For in DHT Evidence

In qointa’s experience the first inspection sets the baseline. What digital-trial evidence inspectors expect, what it is grounded in — and why it must exist before they ask.

Read the summary →
ALCOA+ on the Device: Device-Side Data Integrity in GCP Position papers 8 pages

ALCOA+ on the Device: Device-Side Data Integrity in GCP

When a device captures trial data — a handset, a wearable, a home instrument or the gateway that relays them — attribution, time and protection against alteration are decided on the device, and no validated database can decide them later.

Read the summary →

A paper raised a question about your study?

The people who wrote these papers run the assessments. Bring the device and the protocol; fifteen minutes is enough to know whether it matters for your trial.

Book a 15-minute call